 Peter Rice
Concepts (321)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glucans | 10 | 2017 | 25 | 0.960 |
Why?
| | beta-Glucans | 7 | 2015 | 19 | 0.780 |
Why?
| | Suspensions | 1 | 2017 | 30 | 0.570 |
Why?
| | Hydroxychloroquine | 1 | 2017 | 54 | 0.550 |
Why?
| | Receptors, Immunologic | 6 | 2005 | 201 | 0.400 |
Why?
| | Muscle, Smooth | 4 | 1997 | 144 | 0.400 |
Why?
| | Vas Deferens | 5 | 1997 | 16 | 0.390 |
Why?
| | Skin Absorption | 1 | 2009 | 11 | 0.330 |
Why?
| | Ubiquinone | 1 | 2009 | 21 | 0.320 |
Why?
| | Linoleic Acid | 1 | 2009 | 37 | 0.320 |
Why?
| | Melanocytes | 1 | 2009 | 55 | 0.320 |
Why?
| | Organic Anion Transporters | 3 | 2012 | 15 | 0.300 |
Why?
| | Organic Cation Transport Proteins | 3 | 2012 | 26 | 0.290 |
Why?
| | Rats | 19 | 2012 | 4958 | 0.290 |
Why?
| | beta-Cyclodextrins | 1 | 2007 | 28 | 0.280 |
Why?
| | Nitriles | 1 | 2007 | 149 | 0.270 |
Why?
| | Monocytes | 4 | 2002 | 502 | 0.270 |
Why?
| | Triazoles | 1 | 2007 | 131 | 0.260 |
Why?
| | Intestinal Absorption | 1 | 2005 | 93 | 0.240 |
Why?
| | Candidiasis | 2 | 2020 | 51 | 0.240 |
Why?
| | Chemistry, Pharmaceutical | 3 | 2017 | 98 | 0.230 |
Why?
| | Tachycardia, Supraventricular | 2 | 1995 | 42 | 0.220 |
Why?
| | Epinephrine | 5 | 1997 | 163 | 0.220 |
Why?
| | In Vitro Techniques | 8 | 2009 | 1016 | 0.220 |
Why?
| | Shock, Surgical | 1 | 2003 | 2 | 0.210 |
Why?
| | Dental Care for Chronically Ill | 1 | 2003 | 11 | 0.210 |
Why?
| | Lectins, C-Type | 5 | 2021 | 61 | 0.210 |
Why?
| | Immunity, Innate | 4 | 2015 | 720 | 0.210 |
Why?
| | Lichenoid Eruptions | 1 | 2002 | 3 | 0.210 |
Why?
| | Lichen Planus, Oral | 1 | 2002 | 5 | 0.210 |
Why?
| | Drug Eruptions | 1 | 2002 | 26 | 0.210 |
Why?
| | Adrenal Insufficiency | 1 | 2003 | 26 | 0.210 |
Why?
| | Receptors, LDL | 1 | 2002 | 38 | 0.200 |
Why?
| | Rats, Sprague-Dawley | 6 | 2012 | 2218 | 0.200 |
Why?
| | Imidazoles | 3 | 1998 | 208 | 0.190 |
Why?
| | Cell Adhesion Molecules | 1 | 2002 | 168 | 0.190 |
Why?
| | Animals | 28 | 2020 | 31692 | 0.180 |
Why?
| | Antineoplastic Agents | 2 | 2011 | 1879 | 0.180 |
Why?
| | Candida | 1 | 2020 | 32 | 0.180 |
Why?
| | Biological Availability | 4 | 2012 | 119 | 0.180 |
Why?
| | Polysaccharides | 4 | 2004 | 78 | 0.170 |
Why?
| | Heart | 3 | 1996 | 612 | 0.170 |
Why?
| | Pseudomonas aeruginosa | 1 | 2021 | 298 | 0.170 |
Why?
| | Neurokinin A | 3 | 1997 | 3 | 0.170 |
Why?
| | Adrenal Cortex Hormones | 1 | 2003 | 497 | 0.160 |
Why?
| | Secretin | 1 | 1999 | 4 | 0.160 |
Why?
| | Vasoactive Intestinal Peptide | 1 | 1999 | 15 | 0.160 |
Why?
| | Papillary Muscles | 1 | 1999 | 14 | 0.160 |
Why?
| | Muscle Relaxation | 1 | 1998 | 19 | 0.160 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 1998 | 39 | 0.160 |
Why?
| | Immunologic Factors | 2 | 2017 | 220 | 0.160 |
Why?
| | Receptors, Adrenergic, beta-1 | 1 | 1998 | 45 | 0.150 |
Why?
| | Myometrium | 1 | 1998 | 35 | 0.150 |
Why?
| | Cardiotonic Agents | 1 | 1999 | 119 | 0.150 |
Why?
| | Cyclic AMP | 1 | 1999 | 227 | 0.150 |
Why?
| | Propiophenones | 1 | 1997 | 1 | 0.150 |
Why?
| | Neurotransmitter Uptake Inhibitors | 1 | 1997 | 4 | 0.150 |
Why?
| | Polyethylene Terephthalates | 1 | 2017 | 15 | 0.140 |
Why?
| | Plastics | 1 | 2017 | 35 | 0.140 |
Why?
| | Administration, Oral | 3 | 2007 | 728 | 0.140 |
Why?
| | Immunomodulation | 1 | 2017 | 84 | 0.140 |
Why?
| | Drug Storage | 1 | 2017 | 58 | 0.140 |
Why?
| | Syringes | 1 | 2017 | 41 | 0.140 |
Why?
| | Drug Stability | 1 | 2017 | 151 | 0.140 |
Why?
| | Drug Compounding | 1 | 2017 | 89 | 0.140 |
Why?
| | Ischemic Preconditioning, Myocardial | 1 | 1996 | 29 | 0.130 |
Why?
| | Receptors, Purinergic P1 | 1 | 1996 | 24 | 0.130 |
Why?
| | Chromatography, High Pressure Liquid | 4 | 2009 | 470 | 0.130 |
Why?
| | Moricizine | 1 | 1995 | 1 | 0.130 |
Why?
| | Malassezia | 1 | 2015 | 1 | 0.130 |
Why?
| | Injections, Intravenous | 2 | 2007 | 198 | 0.130 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1995 | 106 | 0.120 |
Why?
| | Biological Products | 1 | 2017 | 166 | 0.120 |
Why?
| | Macrophages | 3 | 2017 | 1261 | 0.120 |
Why?
| | Cytokines | 4 | 2020 | 1840 | 0.120 |
Why?
| | Adenosine | 1 | 1996 | 203 | 0.120 |
Why?
| | Temperature | 1 | 2017 | 565 | 0.120 |
Why?
| | Norepinephrine | 4 | 1992 | 201 | 0.120 |
Why?
| | Saccharomyces cerevisiae | 3 | 2015 | 476 | 0.110 |
Why?
| | Male | 22 | 2020 | 55549 | 0.110 |
Why?
| | Receptors, Adrenergic, alpha | 4 | 1989 | 28 | 0.110 |
Why?
| | Rats, Inbred Strains | 6 | 2008 | 362 | 0.110 |
Why?
| | Benzbromarone | 1 | 2012 | 2 | 0.110 |
Why?
| | Nadolol | 1 | 1992 | 5 | 0.110 |
Why?
| | Nerve Tissue Proteins | 2 | 2008 | 529 | 0.100 |
Why?
| | Phorbol Esters | 1 | 1992 | 15 | 0.100 |
Why?
| | Mice | 8 | 2020 | 14859 | 0.100 |
Why?
| | Isoproterenol | 4 | 1999 | 106 | 0.100 |
Why?
| | Microsomes | 1 | 2011 | 24 | 0.100 |
Why?
| | Membrane Transport Modulators | 1 | 2011 | 6 | 0.100 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2011 | 15 | 0.100 |
Why?
| | Benzoxazoles | 1 | 2011 | 16 | 0.100 |
Why?
| | Binding, Competitive | 5 | 2002 | 193 | 0.090 |
Why?
| | Protein Kinase C | 1 | 1992 | 273 | 0.090 |
Why?
| | Tyrosine | 1 | 2011 | 214 | 0.090 |
Why?
| | Membrane Proteins | 2 | 2008 | 1018 | 0.090 |
Why?
| | Receptors, Cell Surface | 2 | 2004 | 355 | 0.090 |
Why?
| | Cell Line | 7 | 2017 | 2635 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2008 | 1842 | 0.080 |
Why?
| | Electrocardiography | 1 | 1992 | 560 | 0.080 |
Why?
| | Ear, External | 1 | 2009 | 23 | 0.080 |
Why?
| | Humans | 26 | 2021 | 114616 | 0.080 |
Why?
| | Area Under Curve | 2 | 2012 | 274 | 0.080 |
Why?
| | Mass Spectrometry | 2 | 2009 | 633 | 0.080 |
Why?
| | Binding Sites | 5 | 2004 | 1168 | 0.080 |
Why?
| | Vitamin E | 1 | 2008 | 110 | 0.080 |
Why?
| | Solubility | 2 | 2007 | 223 | 0.080 |
Why?
| | Surface-Active Agents | 1 | 2008 | 79 | 0.080 |
Why?
| | Structure-Activity Relationship | 5 | 2012 | 501 | 0.080 |
Why?
| | Reserpine | 2 | 1987 | 4 | 0.080 |
Why?
| | NF-kappa B | 2 | 2002 | 638 | 0.070 |
Why?
| | Cells, Cultured | 3 | 2009 | 3881 | 0.070 |
Why?
| | Catechols | 1 | 1987 | 14 | 0.070 |
Why?
| | Toll-Like Receptor 2 | 2 | 2005 | 110 | 0.070 |
Why?
| | Amidines | 1 | 1987 | 16 | 0.070 |
Why?
| | Capsules | 1 | 2007 | 36 | 0.070 |
Why?
| | Cell Membrane | 4 | 2004 | 680 | 0.070 |
Why?
| | Papain | 1 | 2005 | 3 | 0.060 |
Why?
| | Peyer's Patches | 1 | 2005 | 7 | 0.060 |
Why?
| | Urine | 1 | 2005 | 54 | 0.060 |
Why?
| | Adrenergic alpha-Agonists | 2 | 1997 | 29 | 0.060 |
Why?
| | Drug Contamination | 1 | 2005 | 52 | 0.060 |
Why?
| | Mice, Inbred ICR | 1 | 2005 | 109 | 0.060 |
Why?
| | Polymers | 2 | 2017 | 448 | 0.060 |
Why?
| | Substance Abuse Detection | 1 | 2005 | 62 | 0.060 |
Why?
| | Limulus Test | 1 | 2004 | 8 | 0.060 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1629 | 0.060 |
Why?
| | Muscle, Smooth, Vascular | 1 | 1987 | 411 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1691 | 0.060 |
Why?
| | Half-Life | 1 | 2004 | 141 | 0.060 |
Why?
| | Pituitary Gland, Anterior | 1 | 2004 | 39 | 0.060 |
Why?
| | Dronabinol | 1 | 2005 | 118 | 0.060 |
Why?
| | Neurosecretory Systems | 1 | 2004 | 32 | 0.060 |
Why?
| | Neuroimmunomodulation | 1 | 2004 | 70 | 0.060 |
Why?
| | Myocardial Contraction | 3 | 1999 | 313 | 0.050 |
Why?
| | Mycoses | 1 | 2004 | 66 | 0.050 |
Why?
| | Schools, Dental | 1 | 2003 | 16 | 0.050 |
Why?
| | Poly I | 1 | 2002 | 1 | 0.050 |
Why?
| | Sizofiran | 1 | 2002 | 1 | 0.050 |
Why?
| | Carboxymethylcellulose Sodium | 1 | 2002 | 3 | 0.050 |
Why?
| | Poly C | 1 | 2002 | 3 | 0.050 |
Why?
| | U937 Cells | 1 | 2002 | 22 | 0.050 |
Why?
| | Organizational Policy | 1 | 2003 | 68 | 0.050 |
Why?
| | Receptors, Scavenger | 1 | 2002 | 16 | 0.050 |
Why?
| | Antigens, Fungal | 1 | 2002 | 24 | 0.050 |
Why?
| | United Kingdom | 1 | 2003 | 226 | 0.050 |
Why?
| | Muscle Contraction | 2 | 1997 | 389 | 0.050 |
Why?
| | Linear Models | 1 | 2004 | 768 | 0.050 |
Why?
| | Sex Factors | 1 | 2007 | 1715 | 0.050 |
Why?
| | Lipoproteins, LDL | 1 | 2002 | 128 | 0.050 |
Why?
| | Carbohydrates | 1 | 2021 | 55 | 0.050 |
Why?
| | Hypotension | 1 | 2003 | 116 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2001 | 48 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2002 | 237 | 0.050 |
Why?
| | Staphylococcal Infections | 1 | 2005 | 336 | 0.050 |
Why?
| | Kidney | 3 | 2011 | 1187 | 0.050 |
Why?
| | Consensus | 1 | 2003 | 537 | 0.040 |
Why?
| | Acute Disease | 1 | 2003 | 910 | 0.040 |
Why?
| | Immunity | 1 | 2020 | 121 | 0.040 |
Why?
| | Stress, Physiological | 1 | 2003 | 378 | 0.040 |
Why?
| | Biofilms | 1 | 2021 | 223 | 0.040 |
Why?
| | Virulence | 1 | 2020 | 227 | 0.040 |
Why?
| | Stereoisomerism | 3 | 1989 | 91 | 0.040 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2001 | 194 | 0.040 |
Why?
| | Critical Illness | 1 | 2004 | 644 | 0.040 |
Why?
| | Sympathomimetics | 2 | 1992 | 25 | 0.040 |
Why?
| | Radioligand Assay | 1 | 1998 | 43 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 4689 | 0.040 |
Why?
| | Potassium Chloride | 1 | 1998 | 32 | 0.040 |
Why?
| | Female | 6 | 2007 | 59461 | 0.040 |
Why?
| | Dendritic Cells | 1 | 2021 | 435 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2002 | 1342 | 0.040 |
Why?
| | Protein Binding | 2 | 2017 | 1888 | 0.040 |
Why?
| | Propanolamines | 1 | 1998 | 90 | 0.040 |
Why?
| | Proton Magnetic Resonance Spectroscopy | 1 | 2017 | 20 | 0.040 |
Why?
| | Isotonic Contraction | 1 | 1997 | 2 | 0.040 |
Why?
| | Adrenergic beta-Agonists | 1 | 1998 | 126 | 0.040 |
Why?
| | Catechol O-Methyltransferase | 1 | 1997 | 17 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2001 | 676 | 0.040 |
Why?
| | Skin | 1 | 2001 | 655 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 299 | 0.030 |
Why?
| | Aorta | 3 | 1989 | 386 | 0.030 |
Why?
| | Fibroblasts | 1 | 2001 | 837 | 0.030 |
Why?
| | Purinergic P1 Receptor Agonists | 1 | 1996 | 8 | 0.030 |
Why?
| | Xanthines | 1 | 1996 | 15 | 0.030 |
Why?
| | Adrenergic beta-Antagonists | 1 | 1998 | 287 | 0.030 |
Why?
| | Dogs | 2 | 2011 | 334 | 0.030 |
Why?
| | Tachycardia, Ectopic Atrial | 1 | 1995 | 3 | 0.030 |
Why?
| | Endothelium, Vascular | 1 | 2002 | 843 | 0.030 |
Why?
| | Tachycardia, Ectopic Junctional | 1 | 1995 | 4 | 0.030 |
Why?
| | Receptors, Pattern Recognition | 1 | 2015 | 9 | 0.030 |
Why?
| | Metabolic Clearance Rate | 1 | 1995 | 102 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2001 | 950 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2003 | 1394 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2017 | 493 | 0.030 |
Why?
| | Neutrophil Activation | 1 | 2015 | 94 | 0.030 |
Why?
| | Rabbits | 1 | 1996 | 733 | 0.030 |
Why?
| | Carbohydrate Conformation | 2 | 2008 | 15 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1230 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2020 | 1313 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2011 | 473 | 0.030 |
Why?
| | Prolactin | 2 | 2004 | 96 | 0.030 |
Why?
| | Theophylline | 1 | 1994 | 60 | 0.030 |
Why?
| | MAP Kinase Signaling System | 1 | 2015 | 276 | 0.030 |
Why?
| | Muscle Denervation | 1 | 1992 | 9 | 0.030 |
Why?
| | Phenylephrine | 1 | 1992 | 71 | 0.030 |
Why?
| | Oxymetazoline | 1 | 1991 | 2 | 0.020 |
Why?
| | Chalcones | 1 | 2011 | 9 | 0.020 |
Why?
| | Potassium | 1 | 1992 | 128 | 0.020 |
Why?
| | Anions | 1 | 2011 | 30 | 0.020 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 1991 | 29 | 0.020 |
Why?
| | Macaca fascicularis | 1 | 2011 | 50 | 0.020 |
Why?
| | Microsomes, Liver | 1 | 2011 | 55 | 0.020 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2319 | 0.020 |
Why?
| | Biotransformation | 1 | 2011 | 48 | 0.020 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 1992 | 133 | 0.020 |
Why?
| | Aspirin | 1 | 1994 | 324 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2011 | 286 | 0.020 |
Why?
| | Acetylation | 1 | 2011 | 211 | 0.020 |
Why?
| | Xenopus | 1 | 2011 | 97 | 0.020 |
Why?
| | Uric Acid | 1 | 2011 | 148 | 0.020 |
Why?
| | Intestine, Small | 1 | 2011 | 122 | 0.020 |
Why?
| | Tyramine | 2 | 1987 | 10 | 0.020 |
Why?
| | Kinetics | 2 | 1991 | 1551 | 0.020 |
Why?
| | Drug Design | 1 | 2011 | 148 | 0.020 |
Why?
| | Analysis of Variance | 1 | 1992 | 1226 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2015 | 2565 | 0.020 |
Why?
| | Rhodamine 123 | 1 | 2008 | 3 | 0.020 |
Why?
| | Raloxifene Hydrochloride | 1 | 2008 | 13 | 0.020 |
Why?
| | Caco-2 Cells | 1 | 2008 | 66 | 0.020 |
Why?
| | Portal Vein | 1 | 1989 | 76 | 0.020 |
Why?
| | Mitosporic Fungi | 1 | 2008 | 7 | 0.020 |
Why?
| | Drug Carriers | 1 | 2008 | 112 | 0.020 |
Why?
| | Yeasts | 1 | 2008 | 49 | 0.020 |
Why?
| | Middle Aged | 3 | 2004 | 26719 | 0.020 |
Why?
| | Biological Transport | 1 | 2008 | 373 | 0.020 |
Why?
| | Chemistry | 1 | 1987 | 38 | 0.020 |
Why?
| | Chemical Phenomena | 1 | 1987 | 80 | 0.020 |
Why?
| | Atrial Function | 1 | 1987 | 11 | 0.020 |
Why?
| | Spleen | 1 | 1989 | 487 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2008 | 352 | 0.020 |
Why?
| | Ventricular Function | 1 | 1987 | 57 | 0.020 |
Why?
| | Aged | 2 | 2002 | 19061 | 0.020 |
Why?
| | Heart Rate | 2 | 1987 | 709 | 0.020 |
Why?
| | Adolescent | 2 | 1995 | 17830 | 0.020 |
Why?
| | Ligands | 1 | 2008 | 561 | 0.020 |
Why?
| | Nordazepam | 1 | 2005 | 1 | 0.020 |
Why?
| | Fluorescence Polarization Immunoassay | 1 | 2005 | 2 | 0.020 |
Why?
| | Enzyme Multiplied Immunoassay Technique | 1 | 2005 | 2 | 0.020 |
Why?
| | Sympathectomy | 1 | 1985 | 6 | 0.020 |
Why?
| | Specific Gravity | 1 | 2005 | 11 | 0.020 |
Why?
| | Transfection | 1 | 2008 | 866 | 0.020 |
Why?
| | False Negative Reactions | 1 | 2005 | 48 | 0.020 |
Why?
| | Child | 2 | 1995 | 18402 | 0.020 |
Why?
| | Osmolar Concentration | 1 | 2005 | 173 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2005 | 124 | 0.020 |
Why?
| | Fluorescence | 2 | 2001 | 148 | 0.020 |
Why?
| | Adult | 2 | 2004 | 30528 | 0.020 |
Why?
| | Human Growth Hormone | 1 | 2004 | 38 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2005 | 511 | 0.010 |
Why?
| | Polyethylene Glycols | 1 | 2008 | 561 | 0.010 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2004 | 128 | 0.010 |
Why?
| | Candida albicans | 1 | 2004 | 50 | 0.010 |
Why?
| | Cell Wall | 1 | 2004 | 52 | 0.010 |
Why?
| | Liver | 1 | 2011 | 1633 | 0.010 |
Why?
| | Molecular Conformation | 2 | 2000 | 135 | 0.010 |
Why?
| | Feedback, Physiological | 1 | 2004 | 68 | 0.010 |
Why?
| | Tolazoline | 1 | 1983 | 3 | 0.010 |
Why?
| | Creatinine | 1 | 2005 | 425 | 0.010 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2004 | 81 | 0.010 |
Why?
| | Receptors, Adrenergic | 1 | 1983 | 35 | 0.010 |
Why?
| | Toll-Like Receptors | 1 | 2004 | 167 | 0.010 |
Why?
| | Marijuana Abuse | 1 | 2005 | 212 | 0.010 |
Why?
| | Hydrocortisone | 1 | 2004 | 267 | 0.010 |
Why?
| | Leukemia, Monocytic, Acute | 1 | 2001 | 4 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 430 | 0.010 |
Why?
| | Mannose | 1 | 2001 | 21 | 0.010 |
Why?
| | Awards and Prizes | 1 | 2002 | 56 | 0.010 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2001 | 39 | 0.010 |
Why?
| | Toll-Like Receptor 4 | 1 | 2004 | 287 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2001 | 410 | 0.010 |
Why?
| | Autonomic Fibers, Preganglionic | 1 | 1980 | 4 | 0.010 |
Why?
| | Dopamine beta-Hydroxylase | 1 | 1980 | 12 | 0.010 |
Why?
| | Ganglia, Sympathetic | 1 | 1980 | 18 | 0.010 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 2000 | 37 | 0.010 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 1980 | 68 | 0.010 |
Why?
| | Receptors, Cholinergic | 1 | 1980 | 41 | 0.010 |
Why?
| | Intensive Care Units | 1 | 2004 | 617 | 0.010 |
Why?
| | Biosensing Techniques | 1 | 2001 | 100 | 0.010 |
Why?
| | Solutions | 1 | 2000 | 146 | 0.010 |
Why?
| | Infant | 1 | 1992 | 7954 | 0.010 |
Why?
| | Carcinoma | 1 | 2001 | 198 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2001 | 849 | 0.010 |
Why?
| | Child, Preschool | 1 | 1992 | 9106 | 0.010 |
Why?
| | Opioid-Related Disorders | 1 | 2005 | 413 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 2000 | 301 | 0.010 |
Why?
| | Receptors, Nicotinic | 1 | 1980 | 274 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2001 | 1083 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2004 | 2552 | 0.010 |
Why?
| | Time Factors | 1 | 2005 | 6112 | 0.010 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 1996 | 98 | 0.010 |
Why?
| | Tablets, Enteric-Coated | 1 | 1994 | 4 | 0.010 |
Why?
| | Salicylates | 1 | 1994 | 30 | 0.010 |
Why?
| | Prospective Studies | 1 | 2004 | 6214 | 0.010 |
Why?
| | Drug Interactions | 1 | 1994 | 338 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2001 | 2177 | 0.000 |
Why?
| | Histocytochemistry | 1 | 1985 | 78 | 0.000 |
Why?
| | Histamine | 1 | 1985 | 56 | 0.000 |
Why?
| | Guinea Pigs | 1 | 1985 | 136 | 0.000 |
Why?
| | Optical Rotation | 1 | 1983 | 2 | 0.000 |
Why?
| | Indicators and Reagents | 1 | 1983 | 99 | 0.000 |
Why?
| | Circular Dichroism | 1 | 1983 | 135 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1994 | 6344 | 0.000 |
Why?
| | Risk Factors | 1 | 1994 | 8628 | 0.000 |
Why?
| | Dihydroergotamine | 1 | 1980 | 1 | 0.000 |
Why?
| | Dopa Decarboxylase | 1 | 1980 | 2 | 0.000 |
Why?
| | Chlorisondamine | 1 | 1980 | 4 | 0.000 |
Why?
| | Atropine | 1 | 1980 | 25 | 0.000 |
Why?
| | Receptors, Muscarinic | 1 | 1980 | 17 | 0.000 |
Why?
| | Myocardium | 1 | 1985 | 913 | 0.000 |
Why?
| | Electric Stimulation | 1 | 1980 | 250 | 0.000 |
Why?
|
|
Rice's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|